1 min to read News Posted on April 5, 2023 AZ wins royalties case against GSK over PARP inhibitor Zejula – FiercePharma AZ wins royalties case against GSK over PARP inhibitor Zejula FiercePharma Source: AZ wins royalties case against GSK over PARP inhibitor Zejula – FiercePharma share tweet share Tags: SPACs